Elsevier Inc.

SHERPA: Unknown

People

  1. Kernan
    Kernan
  2. Castro-Malaspina
    Castro-Malaspina
  3. Heller
    Heller
  4. Hsu
    Hsu
  5. Jakubowski
    Jakubowski
  6. O'Reilly
    O'Reilly
  7. Papadopoulos
    Papadopoulos
  8. Perales
    Perales
  9. Young
    Young
  10. Papanicolaou
    Papanicolaou

Groups

  1. Pediatrics, Department of (4)
  2. Stem Cell Transplantation and Cellular Therapy Service (4)
  3. Department of Medicine (3)
  4. Biostatistics Service (2)
  5. Bone Marrow Transplant (2)
  6. Center for Hematologic Malignancies (2)
  7. Epidemiology and Biostatistics (2)
  8. GSK Faculty (2)
  9. Hematologic Malignancies Research (2)
  10. Hematologic Malignancies, Division of (2)
Search Within
  1. "2007"
  2. "Journal article"
  3. "Nancy Kernan"
Formats
  1. Journal Article (4)
Groups
  1. Pediatrics, Department of (4)
  2. Stem Cell Transplantation and Cellular Therapy Service (4)
  3. Department of Medicine (3)
  4. Biostatistics Service (2)
  5. Bone Marrow Transplant (2)
  6. Center for Hematologic Malignancies (2)

More Groups

People
  1. Nancy Kernan (4)
  2. Ann Jakubowski (2)
  3. Esperanza Papadopoulos (2)
  4. Farid Boulad (2)
  5. Glenn Heller (2)
  6. Hugo Castro-Malaspina (2)

More People

Years
  1. 2007 (4)
Publications
  1. Biology of Blood and Marrow Transplantation (4)

Results (4)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted unrelated bone marrow: Analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent craft-versus-host disease
    Journal Article

    van Burik, J. A. H.; Carter, S. L.; Freifeld, A. G.; High, K. P.; Godder, K. T.; Papanicolaou, G. A.; Mendizabal, A. M.; Wagner, J. E.; Yanovich, S.; Kernan, N. A.
    Biology of Blood and Marrow Transplantation (2007)

    Fulltext@MSK | Save
  • Intravenous busulfan and melphalan, tacrolimus, and short-course methotrexate followed by unmodified HLA-matched related or unrelated hematopoietic stem cell transplantation for the treatment of advanced hematologic malignancies
    Journal Article

    Small, T. N.; Young, J. W.; Castro-Malaspina, H.; Prockop, S.; Wilton, A.; Heller, G.; Boulad, F.; Chiu, M.; Hsu, K.; Jakubowski, A.; more...
    Biology of Blood and Marrow Transplantation (2007)

    Fulltext@MSK | Save
  • A scheme for defining cause of death and its application in the T cell depletion trial
    Journal Article

    Copelan, E.; Casper, J. T.; Carter, S. L.; van Burik, J. A. H.; Hurd, D.; Mendizabal, A. M.; Wagner, J. E.; Yanovich, S.; Kernan, N. A.
    Biology of Blood and Marrow Transplantation (2007)

    Fulltext@MSK | Save
  • Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure
    Journal Article

    Chewning, J. H.; Castro-Malaspina, H.; Jakubowski, A.; Kernan, N. A.; Papadopoulos, E. B.; Small, T. N.; Heller, G.; Hsu, K. C.; Perales, M. A.; van den Brink, M. R. M.; more...
    Biology of Blood and Marrow Transplantation (2007)

    Fulltext@MSK | Save